SurModics to Present at Canaccord Genuity Medical Technology and Diagnostics Forum
November 11 2015 - 08:05AM
Business Wire
Webcast is Live on Thursday, November 19, at
11:40 a.m. (ET)
SurModics, Inc. (Nasdaq: SRDX), a leading provider of medical
device and in vitro diagnostic technologies to the healthcare
industry, announced today that Gary Maharaj, president and chief
executive officer, and Andy LaFrence, vice president of finance and
chief financial officer, will make a presentation to the investment
community at the Canaccord Genuity Medical Technology and
Diagnostics Forum in New York City on Thursday, November 19, 2015,
at 11:40 a.m. ET (10:40 a.m. CT).
A live audio webcast of the presentation will be available by
going to the investor relations portion of the Company’s website at
www.surmodics.com and clicking on the webcast icon. An audio replay
will be available beginning at noon CT on Thursday, November 19,
and the webcast will be archived for 90 days.
About SurModics, Inc.SurModics partners with the world's
leading and emerging medical device, diagnostic and life sciences
companies to develop and commercialize innovative products designed
to improve lives by enabling the detection and treatment of
disease. The company’s core offerings include surface modification
coating technologies that impart lubricity, prohealing and
biocompatibility characteristics and components for in vitro
diagnostic test kits and microarrays. SurModics’ strategy is to
build on the product and technical leadership within these fields,
and expand the core offerings to generate opportunities for longer
term sustained growth. SurModics is headquartered in Eden Prairie,
Minnesota. For more information about the Company, visit
www.surmodics.com. The content of SurModics’ website is not part of
this press release or part of any filings that the Company makes
with the SEC.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151111005225/en/
SurModics, Inc.Andy LaFrence,
952-500-7000ir@surmodics.com
SurModics (NASDAQ:SRDX)
Historical Stock Chart
From Feb 2024 to Mar 2024
SurModics (NASDAQ:SRDX)
Historical Stock Chart
From Mar 2023 to Mar 2024